elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q43280791-C656FCA6-D720-4912-B5C0-AE89F0F5A5D9
Q43280791-C656FCA6-D720-4912-B5C0-AE89F0F5A5D9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43280791-C656FCA6-D720-4912-B5C0-AE89F0F5A5D9
Tocilizumab: A Review in Rheumatoid Arthritis.
P2860
Q43280791-C656FCA6-D720-4912-B5C0-AE89F0F5A5D9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43280791-C656FCA6-D720-4912-B5C0-AE89F0F5A5D9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e9996a6c8ea0fe71fc6159a3c2dccc79b6ce96ab
P2860
Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs